Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ATXS Astria Therapeutics Inc

9,65

0,31 (3,32%)

22 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Astria Therapeutics (NASDAQ:ATXS)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Astria Therapeutics Charts.

Astria Therapeutics (NASDAQ:ATXS)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Astria Therapeutics Charts.

News Astria Therapeutics Inc

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Mittwoch 13 November 2024 (2 Wochen vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
Mittwoch 13 November 2024 (2 Wochen vor) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Montag 4 November 2024 (3 Wochen vor) • Business Wire

Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
Mittwoch 30 Oktober 2024 (4 Wochen vor) • Business Wire

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
Montag 21 Oktober 2024 (1 Monat vor) • Business Wire

European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics’ Investigational Therapy for the Treatment of Hereditary Angioedema
Mittwoch 16 Oktober 2024 (1 Monat vor) • Business Wire

Weitere Astria Therapeutics Inc News-Artikel

Deutsche Telekom (QX)

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen